Jefferies on WAVE Life Sciences (WVE): 'We see reasonable bars for WVE's RNA editor to approach target protein levels'
Tweet Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $28.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
